the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin
Official Title Pembrolizumab and Radiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) Not Eligible for Cisplatin Therapy
Principal Investigator Seiwert, Tanguy
Brief Summary This study is being done to evaluate the efficacy of Pembrolizumab, concomitant with and following standard of care definitive radiation, for locally advanced squamous cell carcinoma of the head and neck patients who are not good candidates for Cisplatin.
Gender All
Ages 18 Years
Enrollment 29
Accepts Healthy Volunteers No
Lead Sponsor UNC Lineberger Comprehensive Cancer CenterOther
Collaborator Merck Sharp & Dohme Corp.Industry
Study Design
Study Phase Phase 2
Study Type Interventional
Contact Name Ranee Mehra, MD
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Head and Neck Cancer
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI